Arcellx Inc (ACLX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | ACLX | ADMA | RARE | ||
| Company | Arcellx Inc | Adma Biologics | Ultragenyx Pharmaceu | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 74.16 | 17.16 | 43.48 | ||
| High | 76.41 | 17.96 | 44.45 | ||
| Low | 73.40 | 17.08 | 42.85 | ||
| Last | 75.54 | 17.40 | 44.22 | ||
| Change | +0.33 | -0.50 | +0.75 | ||
| % Change | +0.44% | -2.79% | +1.73% | ||
| Volume | 1,372,200 | 6,941,500 | 1,733,500 | ||
| 20-Day Average Volume | 609,585 | 2,772,595 | 734,305 | ||
| Previous Close | 75.21 | 17.90 | 43.47 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | Yes | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 85.01 | 19.54 | 46.83 | ||
| 20-Day Raw Stochastic | 9.37% | 6.26% | 32.40% | ||
| 20-Day Relative Strength | 39.03% | 41.45% | 37.65% | ||
| Weighted Alpha | +33.76 | +175.06 | -10.31 | ||
| Today's Opinion | 24% Buy | 40% Buy | 56% Sell | ||
| Previous Opinion | 24% Buy | 40% Buy | 56% Sell | ||
| Last Month's Opinion | 88% Buy | 100% Buy | 24% Sell | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | -9.86% since 12/13/24 | -6.40% since 12/13/24 | -3.41% since 12/13/24 | ||
| Low | 73.39 on 12/19/24 | 17.08 on 12/20/24 | 41.45 on 12/19/24 | ||
| High | 85.31 on 12/16/24 | 19.19 on 12/16/24 | 46.75 on 12/16/24 | ||
| 1-Month | |||||
| %Chg | -13.39% since 11/20/24 | -18.58% since 11/20/24 | -4.70% since 11/20/24 | ||
| Low | 73.39 on 12/19/24 | 17.08 on 12/20/24 | 41.45 on 12/19/24 | ||
| High | 96.39 on 12/03/24 | 22.19 on 11/27/24 | 50.00 on 12/10/24 | ||
| 3-Month | |||||
| %Chg | -12.78% since 09/20/24 | -12.91% since 09/20/24 | -24.73% since 09/20/24 | ||
| Low | 73.33 on 10/03/24 | 15.33 on 10/21/24 | 41.45 on 12/19/24 | ||
| High | 107.37 on 11/12/24 | 23.64 on 11/11/24 | 59.50 on 09/23/24 | ||
| 6-Month | |||||
| %Chg | +38.38% since 06/20/24 | +62.46% since 06/20/24 | +16.31% since 06/20/24 | ||
| Low | 49.00 on 08/05/24 | 10.21 on 08/05/24 | 38.24 on 06/21/24 | ||
| High | 107.37 on 11/12/24 | 23.64 on 11/11/24 | 60.37 on 09/16/24 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 4,084,826 | 4,113,186 | 4,083,452 | ||
| Shares Outstanding, K | 54,075 | 236,390 | 92,344 | ||
| Annual Sales | 110,320,000 | 258,220,000 | 434,250,000 | ||
| Annual Net Income | -70,690,000 | -28,240,000 | -606,640,000 | ||
| Last Quarter Sales | 26,030,000 | 119,840,000 | 139,490,000 | ||
| Last Quarter Net Income | -25,870,000 | 35,910,000 | -133,520,000 | ||
| 60-Month Beta | 0.25 | 0.70 | 0.56 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -0.48 on 11/07/24 | 0.15 on 11/07/24 | -1.40 on 11/05/24 | ||
| Latest Earnings Date | 11/11/24 | 11/07/24 | 11/05/24 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 44.75 | 0.00 | ||